Abacus Bioscience
Seattle, WA
Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technology. Our Antigen-Specific Immune Accelerants (ASIA) are POTENT, SPECIFIC and DURABLE, with broad applications across infectious disease and oncology.
abacusbioscience.comCompany Details
Founded
- 2017
Employees
- Between 5 - 10 employees
Raised
- $4,413,591
Headquarters Location
- Seattle, WA
Public
- No
Acquired
- No
CEO
Alan Wahl
Founders
- Craig PhilipsEdward Clark
Company Collections
These are collections Abacus Bioscience is a part of. Click on the collection name to view similar companies.
Abacus Bioscience's Industries
Abacus Bioscience's Tech Stack
Abacus Bioscience Headquarters Location
Seattle, WA 98103
Total Amount Raised: $4,413,591
Abacus Bioscience Funding Rounds
Seed
$4,413,591
Seed Investors
Seagen
Funding info provided by Diffbot.
Abacus Bioscience Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Abacus Bioscience.